Bril WS - Search Results

1

Tolerance to factor VIII in a transgenic mouse expressing human factor VIII cDNA carrying an Arg(593) to Cys substitution.

Bril WS, van Helden PM, Hausl C, Zuurveld MG, Ahmad RU, Hollestelle MJ, Reitsma PH, Fijnvandraat K, van Lier RA, Schwarz HP, Mertens K, Reipert BM, Voorberg J. Bril WS, et al. Thromb Haemost. 2006 Feb;95(2):341-7. doi: 10.1160/TH05-08-0559. Thromb Haemost. 2006. PMID: 16493498

2

Immunobiology of inhibitor development in hemophilia A.

Fijnvandraat K, Bril WS, Voorberg J. Fijnvandraat K, et al. Among authors: bril ws. Semin Thromb Hemost. 2003 Feb;29(1):61-8. doi: 10.1055/s-2003-37940. Semin Thromb Hemost. 2003. PMID: 12640567 Review.

3

HLA class II genotype and factor VIII inhibitors in mild haemophilia A patients with an Arg593 to Cys mutation.

Bril WS, MacLean PE, Kaijen PH, van den Brink EN, Lardy NM, Fijnvandraat K, Peters M, Voorberg J. Bril WS, et al. Haemophilia. 2004 Sep;10(5):509-14. doi: 10.1111/j.1365-2516.2004.01011.x. Haemophilia. 2004. PMID: 15357778

4

Two classes of germline genes both derived from the V(H)1 family direct the formation of human antibodies that recognize distinct antigenic sites in the C2 domain of factor VIII.

van den Brink EN, Bril WS, Turenhout EA, Zuurveld M, Bovenschen N, Peters M, Yee TT, Mertens K, Lewis DA, Ortel TL, Lollar P, Scandella D, Voorberg J. van den Brink EN, et al. Among authors: bril ws. Blood. 2002 Apr 15;99(8):2828-34. doi: 10.1182/blood.v99.8.2828. Blood. 2002. PMID: 11929772 Free article.

5

Analysis of factor VIII inhibitors in a haemophilia A patient with an Arg593-->Cys mutation using phage display.

Bril WS, Turenhout EA, Kaijen PH, van den Brink EN, Koopman MM, Peters M, Voorberg J. Bril WS, et al. Br J Haematol. 2002 Nov;119(2):393-6. doi: 10.1046/j.1365-2141.2002.03856.x. Br J Haematol. 2002. PMID: 12406075 Free article.

6

The mouse homologue of the leukocyte-associated Ig-like receptor-1 is an inhibitory receptor that recruits Src homology region 2-containing protein tyrosine phosphatase (SHP)-2, but not SHP-1.

Lebbink RJ, de Ruiter T, Verbrugge A, Bril WS, Meyaard L. Lebbink RJ, et al. Among authors: bril ws. J Immunol. 2004 May 1;172(9):5535-43. doi: 10.4049/jimmunol.172.9.5535. J Immunol. 2004. PMID: 15100296

7

The Dutch questionnaire-based risk assessment upon hospital admission is unable to identify the majority of carriers of multi-drug-resistant micro-organisms.

Vainio S, Bril W. Vainio S, et al. J Hosp Infect. 2021 Sep;115:124-125. doi: 10.1016/j.jhin.2021.07.001. Epub 2021 Jul 8. J Hosp Infect. 2021. PMID: 34246722 No abstract available.

8

Recommendations for the successful control of a large outbreak of vancomycin-resistant Enterococcus faecium in a non-endemic hospital setting.

Frakking FNJ, Bril WS, Sinnige JC, Klooster JEV, de Jong BAW, van Hannen EJ, Tersmette M. Frakking FNJ, et al. Among authors: bril ws. J Hosp Infect. 2018 Dec;100(4):e216-e225. doi: 10.1016/j.jhin.2018.02.016. Epub 2018 Feb 21. J Hosp Infect. 2018. PMID: 29475013 Free article.

9

Validation of an algorithm for semiautomated surveillance to detect deep surgical site infections after primary total hip or knee arthroplasty-A multicenter study.

Verberk JDM, van Rooden SM, Koek MBG, Hetem DJ, Smilde AE, Bril WS, Streefkerk RHRA, Hopmans TEM, Bonten MJM, de Greeff SC, van Mourik MSM. Verberk JDM, et al. Among authors: bril ws. Infect Control Hosp Epidemiol. 2021 Jan;42(1):69-74. doi: 10.1017/ice.2020.377. Epub 2020 Aug 28. Infect Control Hosp Epidemiol. 2021. PMID: 32856575

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

9 results

Search Page